

Deficiency of Adenosine Deaminase 2 (DADA 2)
Dec 17, 2024
Dr. Pui Y. Lee, a pediatric rheumatologist at Boston Children's Hospital and assistant professor at Harvard Medical School, shares his expertise on Deficiency of Adenosine Deaminase 2 (DADA2). He discusses the rarity of this hereditary auto-inflammatory disease and its diverse symptoms. The conversation dives into the significance of genetic testing and the challenges in diagnosis and treatment, including the ethical concerns surrounding pre-symptomatic care. Lee highlights innovative treatments like gene therapy and the importance of collaborative care for better patient outcomes.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 3min
Unraveling DADA2: A Rare Genetic Syndrome
03:19 • 19min
Understanding DADA2: Phenotypes and Therapeutic Approaches
21:55 • 9min
Navigating Genetic Testing and Treatment Options for DADA 2
30:33 • 4min
Navigating Insurance Approvals for TNF Inhibitors
34:32 • 2min
Navigating DADA2 Treatment Options
36:21 • 5min
Comparative Analysis of DADA 2 and Vexus Syndrome
41:41 • 2min
Understanding DADA 2: Challenges and Innovations
44:10 • 6min